These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32513545)

  • 1. Effectiveness of ECT in Management of Depression in patients with schizophrenia: An Open Labelled Study.
    Grover S; Shouan A; Chakrabarti S; Sahoo S; Mehra A
    Schizophr Res; 2020 Aug; 222():530-531. PubMed ID: 32513545
    [No Abstract]   [Full Text] [Related]  

  • 2. Relief of expressed suicidality in schizophrenia after electroconvulsive therapy: A naturalistic cohort study.
    Tor PC; Bin Abdin E; Hadzi-Pavlovic D; Loo C
    Psychiatry Res; 2020 Feb; 284():112759. PubMed ID: 31927303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin and prolactin responses to ECT in schizophrenia and depression.
    Papakostas Y; Markianos M; Papadimitriou G; Lykouras L; Stefanis C
    Psychiatry Res; 1991 Apr; 37(1):5-10. PubMed ID: 1862162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of severely depressed schizophrenic patients.
    Sim M
    Am J Psychother; 1978 Jan; 32(1):74-80. PubMed ID: 26224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Electroconvulsive Therapy and Associated Cognitive Change in Schizophrenia: A Naturalistic, Comparative Study of Treating Schizophrenia With Electroconvulsive Therapy.
    Tor PC; Ying J; Ho NF; Wang M; Martin D; Ang CP; Tan C; Yap LS; Lu VJM; Simpson B; Mok YM; Loo C
    J ECT; 2017 Dec; 33(4):272-277. PubMed ID: 28640170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepancy in research on ECT in schizophrenia and depression: a global perspective.
    Mahadevaiah M; Thirthalli J; Gangadhar BN
    World J Biol Psychiatry; 2010 Dec; 11(8):997-8. PubMed ID: 20873972
    [No Abstract]   [Full Text] [Related]  

  • 8. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia--an open label study.
    Kho KH; Blansjaar BA; de Vries S; Babuskova D; Zwinderman AH; Linszen DH
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):372-9. PubMed ID: 15538604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies.
    Greenhalgh J; Knight C; Hind D; Beverley C; Walters S
    Health Technol Assess; 2005 Mar; 9(9):1-156, iii-iv. PubMed ID: 15774232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of ECT combined with risperidone against aggression in schizophrenia.
    Hirose S; Ashby CR; Mills MJ
    J ECT; 2001 Mar; 17(1):22-6. PubMed ID: 11281510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: A retrospective study.
    Grover S; Chakrabarti S; Hazari N; Avasthi A
    Psychiatry Res; 2017 Mar; 249():349-353. PubMed ID: 28152470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria.
    Ikeji OC; Ohaeri JU; Osahon RO; Agidee RO
    East Afr Med J; 1999 Nov; 76(11):644-50. PubMed ID: 10734527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First rank symptoms as predictors of ECT response in schizophrenia.
    Koehler K; Sauer H
    Br J Psychiatry; 1983 Mar; 142():280-3. PubMed ID: 6860880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leicester ECT trial: results in schizophrenia.
    Brandon S; Cowley P; McDonald C; Neville P; Palmer R; Wellstood-Eason S
    Br J Psychiatry; 1985 Feb; 146():177-83. PubMed ID: 3884080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind randomized controlled study showing symptomatic and cognitive superiority of bifrontal over bitemporal electrode placement during electroconvulsive therapy for schizophrenia.
    Phutane VH; Thirthalli J; Muralidharan K; Naveen Kumar C; Keshav Kumar J; Gangadhar BN
    Brain Stimul; 2013 Mar; 6(2):210-7. PubMed ID: 22560048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.
    Tang WK; Ungvari GS
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):373-9. PubMed ID: 12691772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of brief and ultrabrief pulse stimuli in unilateral ECT.
    Pisvejc J; Hyrman V; Sikora J; Berankova A; Kobeda B; Auerova M; Sochorova V
    J ECT; 1998 Jun; 14(2):68-75. PubMed ID: 9641801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyamine oxidase activity in sera of depressed and schizophrenic patients after ECT treatment.
    Dahel KA; Al-Saffar NM; Flayeh KA
    Neurochem Res; 2001 Apr; 26(4):415-8. PubMed ID: 11495353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do ictal EEG characteristics predict treatment outcomes in schizophrenic patients undergoing electroconvulsive therapy?
    Simsek GG; Zincir S; Gulec H; Eksioglu S; Semiz UB; Kurtulmus YS
    Nord J Psychiatry; 2015 Aug; 69(6):466-71. PubMed ID: 25731192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convulsive therapy in schizophrenia?
    Fink M; Sackeim HA
    Schizophr Bull; 1996; 22(1):27-39. PubMed ID: 8685661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.